Jane Street’s Entera Bio ENTX Stock Holding History

Jane Street’s Portfolio ENTX Stock Details ENTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$36.5K	Sell	32,915 -41,149	-56%	-$57.7K	﹤0.01%	11070
2025 Q4	$144K	Buy	74,064 +43,536	+143%	+$102K	﹤0.01%	9966
2025 Q3	$58.6K	Buy	30,528 +20,341	+200%	+$38.9K	﹤0.01%	10304
2025 Q2	$19.4K	Buy	+10,187	New	+$20.1K	﹤0.01%	9363
2021 Q4	–	Sell	-11,563	Closed	-$54K	–	10238
2021 Q3	$54K	Buy	+11,563	New	+$59.3K	﹤0.01%	9526

Other funds holding ENTX

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SFCM

Seven Fleet Capital Management Mountain View, California $318M AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

SEIA

Signature Estate & Investment Advisors Los Angeles, California $5.56B AUM 26.66% 1-Year Est. Return

Jane Street's ENTX Position: Q1 2026 in Review

Jane Street reduced its Entera Bio (ENTX) stake by 56% in Q1 2026, selling an estimated $57.7K and leaving 32,915 shares worth $36.5K. The position accounts for ﹤0.01% of the portfolio, ranked #11070.

Jane Street first reported a position in ENTX in Q3 2021 and has held it in 5 quarters since. The position peaked at $144K in Q4 2025. 26 funds tracked by Wall St. Rank hold ENTX as of Q1 2026.

Jane Street held 32,915 shares of Entera Bio worth $36.5K as of Q1 2026.
Jane Street sold 41,149 Entera Bio shares in Q1 2026, an estimated $57.7K.
Entera Bio made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #11070 holding.
Jane Street first reported a position in Entera Bio in Q3 2021 and has held it in 5 quarters since.
Jane Street's Entera Bio position peaked at $144K in Q4 2025.
26 funds tracked by Wall St. Rank held Entera Bio as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.